Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-094011)

Filing Details

Accession Number:: 0000950170-25-094011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-07-03 18:00:07
Reporting Period:: 2025-07-01

Filing Date:: 2025-07-03
Accepted Time:: 2025-07-03 18:00:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1744659	Akero Therapeutics Inc.	AKRO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1961273	Patrick Lamy	C/O Akero Therapeutics, Inc. 601 Gateway Blvd, Suite 350 South San Francisco CA 94080	Senior Vp, Commercial Strategy	No	No	No	No

Transaction Summary

Sold:	2,000 shares	Avg. Price: $52.88	Total Value: $105,760.00
Number of Shares After Transactions:	29,891 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-07-01	2,000	$52.88	29,891	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 6, 2025, previously adopted by the Reporting Person.